NCT00289588View on ClinicalTrials.gov

An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers

NACompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

December 31, 2005

Conditions
Community-Acquired MRSA InfectionsAbscessesCellulitisFolliculitis
Interventions
DRUG

Mupirocin (drug)

Trial Locations (1)

78234

Brooke Army Medical Center, Fort Sam Houston

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Becton, Dickinson and Company

INDUSTRY

lead

Brooke Army Medical Center

FED